Rani Therapeutics price target lowered to $9 from $13 at H.C. Wainwright
PremiumThe FlyRani Therapeutics price target lowered to $9 from $13 at H.C. Wainwright
3M ago
Rani Therapeutics reports Q2 EPS (26c), consensus (32c)
Premium
The Fly
Rani Therapeutics reports Q2 EPS (26c), consensus (32c)
3M ago
Rani Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Rani Therapeutics initiated with an Outperform at Oppenheimer
3M ago
Rani Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyRani Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
Rani Therapeutics price target raised to $14 from $7 at BTIG
Premium
The Fly
Rani Therapeutics price target raised to $14 from $7 at BTIG
6M ago
Rani Therapeutics price target raised to $13 from $12 at H.C. Wainwright
Premium
The Fly
Rani Therapeutics price target raised to $13 from $12 at H.C. Wainwright
6M ago
Rani Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
PremiumThe FlyRani Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
8M ago
Rani Therapeutics reports Q4 EPS (27c), consensus (31c)
Premium
The Fly
Rani Therapeutics reports Q4 EPS (27c), consensus (31c)
8M ago
RANI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RANI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100